A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

BIIB080 is an antisense oligonucleotide therapy designed to target microtubule-associated protein tau mRNA and reduce the production of tau.

Big Pharma-backed Atalanta Therapeutics is ramping up for the clinical debut of the company’s lead epilepsy asset in the wake of new data showing the RNA therapy ...

US biotech Merida Biosciences has launched with $121m in Series A financing to develop therapeutics targeting disease-causing ...

Opinion: McDermott, Will & Emery's Byron Kalogerou and Meredith Cullen Schwartz say demand in the anti-obesity market and new ...

Meanwhile, Biogen also reported data from a long-term ... and also cut plasma levels of a biomarker protein called p-tau181 at week 128, according to a presentation of the data at the ...

Biogen has revealed encouraging phase 2 results ... is an autoimmune kidney disease driven by immune cells that express a protein called CD38 on their surface. It is thought that CD38-expressing ...

Canada Gairdner Awards recognize the world’s most accomplished researchers whose work is improving our understanding of human ...

Biosimilar challenges include complex manufacturing processes and regulatory obstacles, offset by less regulated market ...

Biogen Pharmachem Industries Ltd share price was down by -3.16% from the previous closing price of ₹0.95. Who are peers of Biogen Pharmachem Industries Ltd? The peers of Biogen Pharmachem ...

Best whey-protein powders Best collagen-protein powder Best plant-based protein powders All the other protein powders I’ve tried Protein powders can be found in thousands of formulations on tens ...